Clinical Trial: A Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Female Contraception

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222228) titled 'A Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Female Contraception' on Oct. 22.

Brief Summary: This is a multicenter, open-label, Phase 2b study to evaluate the efficacy and safety of 2 LB SQ injections administered at a 4-month (approximately 17 weeks) interval for female contraception.

Study Start Date: April 01, 2026

Study Type: INTERVENTIONAL

Condition: Healthy Women Female Contraception

Intervention: DRUG: Levonorgestrel butanoate

60 mg SQ (70 mg/mL)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Premier Research

Information provided by (Responsible Party): Clint Dart, Premi...